Stock CHRO CHROMOCELL THERAPEUTICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Chromocell Therapeutics Corporation

Equities

CHRO

US1711261057

Market Closed - Nyse
Other stock markets
 21:10:00 31/05/2024 BST 		5-day change 1st Jan Change
1.34 USD -5.63% Intraday chart for Chromocell Therapeutics Corporation -6.57% -.--%
05-15 Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-16 Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CHROMOCELL THERAPEUTICS CORPORATION Stock Chromocell Therapeutics Corporation
 7.88M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. CHRO Stock
  4. Charts Chromocell Therapeutics Corporation
  5. Sector Chart